Time course and clinical characterization of cisplatin‐induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population

Background The purpose of this study was to characterize the clinical course of hearing loss in patients with nasopharyngeal carcinoma (NPC) and the clinical factors affecting its severity. Methods The time course of hearing loss in patients with NPC was assessed using threshold shift from baseline...

Full description

Saved in:
Bibliographic Details
Published in:Head & neck 2018-07, Vol.40 (7), p.1425-1433
Main Authors: Chan, Sze Ling, Ng, Li Shia, Goh, Xueying, Siow, Chor Hiang, Goh, Han Lee, Goh, Boon Cher, Cheo, Timothy, Loh, Kwok Seng, Brunham, Liam R.
Format: Article
Language:English
Subjects:
Asian
Chemoradiotherapy
Chemotherapy
Cisplatin
Cochlea
Head and neck
Hearing loss
Nasopharyngeal carcinoma
Ototoxicity
Patients
Radiation therapy
radiotherapy
Terminology
Throat cancer
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3532-def2aea09cdce7a01922d6658ce4dca46368e6e047081596843b9617a51b1d333
cites cdi_FETCH-LOGICAL-c3532-def2aea09cdce7a01922d6658ce4dca46368e6e047081596843b9617a51b1d333
container_end_page 1433
container_issue 7
container_start_page 1425
container_title Head & neck
container_volume 40
creator Chan, Sze Ling
Ng, Li Shia
Goh, Xueying
Siow, Chor Hiang
Goh, Han Lee
Goh, Boon Cher
Cheo, Timothy
Loh, Kwok Seng
Brunham, Liam R.
description Background The purpose of this study was to characterize the clinical course of hearing loss in patients with nasopharyngeal carcinoma (NPC) and the clinical factors affecting its severity. Methods The time course of hearing loss in patients with NPC was assessed using threshold shift from baseline and Common Terminology Criteria for Adverse Events (CTCAE) grade. Results In the chemoradiotherapy (CRT) groups, the threshold shift was significantly higher from 3 months at 4 kHz (P = 2.30 × 10−9, concurrent CRT only) but not within 2 years posttreatment in the radiotherapy (RT) group. The CRT groups had worse CTCAE grades than the RT group (percentage of latest CTCAE grade ≥1: 64.9% vs 29.0%, respectively). Cumulative cisplatin dose and cochlear RT dose significantly affects threshold shifts, especially at high frequencies. Conclusion Although cisplatin led to high frequency hearing impairment from about 3 months posttreatment, RT conferred no significant hearing impairment in the first 2 years.
doi_str_mv 10.1002/hed.25112
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2003044873</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2066197052</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3532-def2aea09cdce7a01922d6658ce4dca46368e6e047081596843b9617a51b1d333</originalsourceid><addsrcrecordid>eNp1kctu1DAUhq2Kqi2FBS-ALLGBRVrf4iTLqgwUqVIXlHV0xj5hXCV2sB2VYcUjsObxeBI8nXaDhLzwRZ--Y_0_Ia84O-OMifMN2jNRcy4OyAlnXVMxqZpnu7OSlWSNOibPU7pjjEmtxBE5Fp2qeVfzE_L71k1ITVhiQgreUjM67wyM1GwggskY3Q_ILngaBmpcmsdy839-_nLeLgYtDbms7864vKUwFJ7miJAn9JkOIVIPKczFtfVfcaeFaJwPE1DnKdDPYckbuoKU6UVy4Okc5mV8GPiCHA4wJnz5uJ-SLx9Wt5dX1fXNx0-XF9eVkbUUlcVBAALrjDXYAOOdEFbrujWorAGlpW5RI1MNa3nd6VbJdad5AzVfcyulPCVv9945hm8LptxPLhkcR_AYltSLEhtTqm126Jt_0LuSnC-_K5TWvGtYLQr1bk-ZGFKKOPRzdFNJoOes3xXWl8L6h8IK-_rRuKyn8vpEPjVUgPM9cO9G3P7f1F-t3u-VfwGazaK0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2066197052</pqid></control><display><type>article</type><title>Time course and clinical characterization of cisplatin‐induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Chan, Sze Ling ; Ng, Li Shia ; Goh, Xueying ; Siow, Chor Hiang ; Goh, Han Lee ; Goh, Boon Cher ; Cheo, Timothy ; Loh, Kwok Seng ; Brunham, Liam R.</creator><creatorcontrib>Chan, Sze Ling ; Ng, Li Shia ; Goh, Xueying ; Siow, Chor Hiang ; Goh, Han Lee ; Goh, Boon Cher ; Cheo, Timothy ; Loh, Kwok Seng ; Brunham, Liam R.</creatorcontrib><description>Background The purpose of this study was to characterize the clinical course of hearing loss in patients with nasopharyngeal carcinoma (NPC) and the clinical factors affecting its severity. Methods The time course of hearing loss in patients with NPC was assessed using threshold shift from baseline and Common Terminology Criteria for Adverse Events (CTCAE) grade. Results In the chemoradiotherapy (CRT) groups, the threshold shift was significantly higher from 3 months at 4 kHz (P = 2.30 × 10−9, concurrent CRT only) but not within 2 years posttreatment in the radiotherapy (RT) group. The CRT groups had worse CTCAE grades than the RT group (percentage of latest CTCAE grade ≥1: 64.9% vs 29.0%, respectively). Cumulative cisplatin dose and cochlear RT dose significantly affects threshold shifts, especially at high frequencies. Conclusion Although cisplatin led to high frequency hearing impairment from about 3 months posttreatment, RT conferred no significant hearing impairment in the first 2 years.</description><identifier>ISSN: 1043-3074</identifier><identifier>EISSN: 1097-0347</identifier><identifier>DOI: 10.1002/hed.25112</identifier><identifier>PMID: 29451951</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Asian ; Chemoradiotherapy ; Chemotherapy ; Cisplatin ; Cochlea ; Head and neck ; Hearing loss ; Nasopharyngeal carcinoma ; Ototoxicity ; Patients ; Radiation therapy ; radiotherapy ; Terminology ; Throat cancer</subject><ispartof>Head &amp; neck, 2018-07, Vol.40 (7), p.1425-1433</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3532-def2aea09cdce7a01922d6658ce4dca46368e6e047081596843b9617a51b1d333</citedby><cites>FETCH-LOGICAL-c3532-def2aea09cdce7a01922d6658ce4dca46368e6e047081596843b9617a51b1d333</cites><orcidid>0000-0002-3686-3807</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29451951$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, Sze Ling</creatorcontrib><creatorcontrib>Ng, Li Shia</creatorcontrib><creatorcontrib>Goh, Xueying</creatorcontrib><creatorcontrib>Siow, Chor Hiang</creatorcontrib><creatorcontrib>Goh, Han Lee</creatorcontrib><creatorcontrib>Goh, Boon Cher</creatorcontrib><creatorcontrib>Cheo, Timothy</creatorcontrib><creatorcontrib>Loh, Kwok Seng</creatorcontrib><creatorcontrib>Brunham, Liam R.</creatorcontrib><title>Time course and clinical characterization of cisplatin‐induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population</title><title>Head &amp; neck</title><addtitle>Head Neck</addtitle><description>Background The purpose of this study was to characterize the clinical course of hearing loss in patients with nasopharyngeal carcinoma (NPC) and the clinical factors affecting its severity. Methods The time course of hearing loss in patients with NPC was assessed using threshold shift from baseline and Common Terminology Criteria for Adverse Events (CTCAE) grade. Results In the chemoradiotherapy (CRT) groups, the threshold shift was significantly higher from 3 months at 4 kHz (P = 2.30 × 10−9, concurrent CRT only) but not within 2 years posttreatment in the radiotherapy (RT) group. The CRT groups had worse CTCAE grades than the RT group (percentage of latest CTCAE grade ≥1: 64.9% vs 29.0%, respectively). Cumulative cisplatin dose and cochlear RT dose significantly affects threshold shifts, especially at high frequencies. Conclusion Although cisplatin led to high frequency hearing impairment from about 3 months posttreatment, RT conferred no significant hearing impairment in the first 2 years.</description><subject>Asian</subject><subject>Chemoradiotherapy</subject><subject>Chemotherapy</subject><subject>Cisplatin</subject><subject>Cochlea</subject><subject>Head and neck</subject><subject>Hearing loss</subject><subject>Nasopharyngeal carcinoma</subject><subject>Ototoxicity</subject><subject>Patients</subject><subject>Radiation therapy</subject><subject>radiotherapy</subject><subject>Terminology</subject><subject>Throat cancer</subject><issn>1043-3074</issn><issn>1097-0347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kctu1DAUhq2Kqi2FBS-ALLGBRVrf4iTLqgwUqVIXlHV0xj5hXCV2sB2VYcUjsObxeBI8nXaDhLzwRZ--Y_0_Ia84O-OMifMN2jNRcy4OyAlnXVMxqZpnu7OSlWSNOibPU7pjjEmtxBE5Fp2qeVfzE_L71k1ITVhiQgreUjM67wyM1GwggskY3Q_ILngaBmpcmsdy839-_nLeLgYtDbms7864vKUwFJ7miJAn9JkOIVIPKczFtfVfcaeFaJwPE1DnKdDPYckbuoKU6UVy4Okc5mV8GPiCHA4wJnz5uJ-SLx9Wt5dX1fXNx0-XF9eVkbUUlcVBAALrjDXYAOOdEFbrujWorAGlpW5RI1MNa3nd6VbJdad5AzVfcyulPCVv9945hm8LptxPLhkcR_AYltSLEhtTqm126Jt_0LuSnC-_K5TWvGtYLQr1bk-ZGFKKOPRzdFNJoOes3xXWl8L6h8IK-_rRuKyn8vpEPjVUgPM9cO9G3P7f1F-t3u-VfwGazaK0</recordid><startdate>201807</startdate><enddate>201807</enddate><creator>Chan, Sze Ling</creator><creator>Ng, Li Shia</creator><creator>Goh, Xueying</creator><creator>Siow, Chor Hiang</creator><creator>Goh, Han Lee</creator><creator>Goh, Boon Cher</creator><creator>Cheo, Timothy</creator><creator>Loh, Kwok Seng</creator><creator>Brunham, Liam R.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3686-3807</orcidid></search><sort><creationdate>201807</creationdate><title>Time course and clinical characterization of cisplatin‐induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population</title><author>Chan, Sze Ling ; Ng, Li Shia ; Goh, Xueying ; Siow, Chor Hiang ; Goh, Han Lee ; Goh, Boon Cher ; Cheo, Timothy ; Loh, Kwok Seng ; Brunham, Liam R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3532-def2aea09cdce7a01922d6658ce4dca46368e6e047081596843b9617a51b1d333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Asian</topic><topic>Chemoradiotherapy</topic><topic>Chemotherapy</topic><topic>Cisplatin</topic><topic>Cochlea</topic><topic>Head and neck</topic><topic>Hearing loss</topic><topic>Nasopharyngeal carcinoma</topic><topic>Ototoxicity</topic><topic>Patients</topic><topic>Radiation therapy</topic><topic>radiotherapy</topic><topic>Terminology</topic><topic>Throat cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, Sze Ling</creatorcontrib><creatorcontrib>Ng, Li Shia</creatorcontrib><creatorcontrib>Goh, Xueying</creatorcontrib><creatorcontrib>Siow, Chor Hiang</creatorcontrib><creatorcontrib>Goh, Han Lee</creatorcontrib><creatorcontrib>Goh, Boon Cher</creatorcontrib><creatorcontrib>Cheo, Timothy</creatorcontrib><creatorcontrib>Loh, Kwok Seng</creatorcontrib><creatorcontrib>Brunham, Liam R.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Head &amp; neck</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, Sze Ling</au><au>Ng, Li Shia</au><au>Goh, Xueying</au><au>Siow, Chor Hiang</au><au>Goh, Han Lee</au><au>Goh, Boon Cher</au><au>Cheo, Timothy</au><au>Loh, Kwok Seng</au><au>Brunham, Liam R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Time course and clinical characterization of cisplatin‐induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population</atitle><jtitle>Head &amp; neck</jtitle><addtitle>Head Neck</addtitle><date>2018-07</date><risdate>2018</risdate><volume>40</volume><issue>7</issue><spage>1425</spage><epage>1433</epage><pages>1425-1433</pages><issn>1043-3074</issn><eissn>1097-0347</eissn><abstract>Background The purpose of this study was to characterize the clinical course of hearing loss in patients with nasopharyngeal carcinoma (NPC) and the clinical factors affecting its severity. Methods The time course of hearing loss in patients with NPC was assessed using threshold shift from baseline and Common Terminology Criteria for Adverse Events (CTCAE) grade. Results In the chemoradiotherapy (CRT) groups, the threshold shift was significantly higher from 3 months at 4 kHz (P = 2.30 × 10−9, concurrent CRT only) but not within 2 years posttreatment in the radiotherapy (RT) group. The CRT groups had worse CTCAE grades than the RT group (percentage of latest CTCAE grade ≥1: 64.9% vs 29.0%, respectively). Cumulative cisplatin dose and cochlear RT dose significantly affects threshold shifts, especially at high frequencies. Conclusion Although cisplatin led to high frequency hearing impairment from about 3 months posttreatment, RT conferred no significant hearing impairment in the first 2 years.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29451951</pmid><doi>10.1002/hed.25112</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-3686-3807</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1043-3074
ispartof Head & neck, 2018-07, Vol.40 (7), p.1425-1433
issn 1043-3074
1097-0347
language eng
recordid cdi_proquest_miscellaneous_2003044873
source Wiley-Blackwell Read & Publish Collection
subjects Asian
Chemoradiotherapy
Chemotherapy
Cisplatin
Cochlea
Head and neck
Hearing loss
Nasopharyngeal carcinoma
Ototoxicity
Patients
Radiation therapy
radiotherapy
Terminology
Throat cancer
title Time course and clinical characterization of cisplatin‐induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T09%3A15%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Time%20course%20and%20clinical%20characterization%20of%20cisplatin%E2%80%90induced%20ototoxicity%20after%20treatment%20for%20nasopharyngeal%20carcinoma%20in%20a%20South%20East%20Asian%20population&rft.jtitle=Head%20&%20neck&rft.au=Chan,%20Sze%20Ling&rft.date=2018-07&rft.volume=40&rft.issue=7&rft.spage=1425&rft.epage=1433&rft.pages=1425-1433&rft.issn=1043-3074&rft.eissn=1097-0347&rft_id=info:doi/10.1002/hed.25112&rft_dat=%3Cproquest_cross%3E2066197052%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3532-def2aea09cdce7a01922d6658ce4dca46368e6e047081596843b9617a51b1d333%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2066197052&rft_id=info:pmid/29451951&rfr_iscdi=true